Belite Bio, Inc (BLTE)

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $6.66 billion. The enterprise value is $6.86 billion.

Market Cap	6.66B
Enterprise Value	6.86B

Important Dates

The next confirmed earnings date is Monday, March 2, 2026, before market open.

Earnings Date	Mar 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 37.51 million shares outstanding. The number of shares has increased by 9.82% in one year.

Current Share Class	n/a
Shares Outstanding	37.51M
Shares Change (YoY)	+9.82%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	11.29%
Float	16.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.72
P/TBV Ratio	8.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 49.08

Current Ratio	49.08
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.94% and return on invested capital (ROIC) is -11.48%.

Return on Equity (ROE)	-16.94%
Return on Assets (ROA)	-11.29%
Return on Invested Capital (ROIC)	-11.48%
Return on Capital Employed (ROCE)	-10.93%
Weighted Average Cost of Capital (WACC)	-3.80%
Revenue Per Employee	n/a
Profits Per Employee	-$3.10M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +216.43% in the last 52 weeks. The beta is -1.46, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.46
52-Week Price Change	+216.43%
50-Day Moving Average	168.23
200-Day Moving Average	103.07
Relative Strength Index (RSI)	54.20
Average Volume (20 Days)	198,816

Short Selling Information

Short Interest	681,671
Short Previous Month	585,301
Short % of Shares Out	3.41%
Short % of Float	n/a
Short Ratio (days to cover)	3.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-84.21M
Pretax Income	-77.61M
Net Income	-77.61M
EBITDA	-84.03M
EBIT	-84.21M
Earnings Per Share (EPS)	-$2.31

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	770.49M
Book Value Per Share	19.59
Working Capital	484.20M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.82%
Shareholder Yield	-9.82%
Earnings Yield	-1.16%
FCF Yield	n/a

Analyst Forecast

The average price target for Belite Bio is $161.57, which is -9.02% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$161.57
Price Target Difference	-9.02%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1